Dahlin JS, Hallgren J. Mast cell progenitors: origin, development and migration to tissues. Mol Immunol. 2015;63(1):9–17.

Article  CAS  PubMed  Google Scholar 

Valent P, Akin C, Hartmann K, Nilsson G, Reiter A, Hermine O, et al. Mast cells as a unique hematopoietic lineage and cell system: from Paul Ehrlich’s visions to precision medicine concepts. Theranostics. 2020;10(23):10743–68.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Voelker D, Pongdee T. Biomarkers in the diagnosis of mast cell activation. Curr Opin Allergy Clin Immunol. 2025;25(1):27–33.

CAS  PubMed  Google Scholar 

Garcia-Montero AC, Jara-Acevedo M, Teodosio C, Sanchez ML, Nunez R, Prados A. KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. Blood. 2006;108(7):2366–72.

Article  CAS  PubMed  Google Scholar 

Valent P, Hartmann K, Bonadonna P, Gülen T, Brockow K, Alvarez-Twose I, et al. Global classification of mast cell activation disorders: an ICD-10-CM–adjusted proposal of the ECNM-AIM consortium. J Allergy Clin Immunol Pract. 2022. https://doi.org/10.1016/j.jaip.2022.05.007.

Article  PubMed  Google Scholar 

Valent P, Hartmann K, Bonadonna P, Niedoszytko M, Triggiani M, Arock M, et al. Mast Cell Activation Syndromes: Collegium Internationale Allergologicum Update 2022. International Archives of Allergy and Immunology: S. Karger AG; 2022. p. 693–705.

Valent P, Akin C. Doctor, i think i am suffering from MCAS: differential diagnosis and separating facts from fiction. J Allergy Clin Immunol Pract. 2019;7(4):1109–14.

Article  PubMed  Google Scholar 

Butterfield J, Weiler CR. The utility of measuring urinary metabolites of mast cell mediators in systemic mastocytosis and mast cell activation syndrome. J Allergy Clin Immunol Pract. 2020;8(8):2533–41.

Article  PubMed  Google Scholar 

Valent P, Bonadonna P, Hartmann K, Broesby-Olsen S, Brockow K, Butterfield JH, et al. Why the 20% + 2 tryptase formula is a diagnostic gold standard for severe systemic mast cell activation and mast cell activation syndrome. Int Arch Allergy Immunol. 2019. https://doi.org/10.1159/000501079.

Article  PubMed  PubMed Central  Google Scholar 

Korosec P, Gonzalez-de-Olano D, Lyons JJ. Alpha-tryptase overexpression as a modifier of mast cell-mediated reactions. J Allergy Clin Immunol Pract. 2025;13(12):3180–6.

Article  CAS  PubMed  Google Scholar 

Lyons JJ, Yu X, Hughes JD, Le QT, Jamil A, Bai Y, et al. Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number. Nat Genet. 2016;48(12):1564–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schwartz LB, Metcalfe DD, Miller JS, Earl H, Sullivan T. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med. 1987;316:1622–6.

Article  CAS  PubMed  Google Scholar 

Hallgren J, Pejler G. Biology of mast cell tryptase: an inflammatory mediator. FEBS J. 2006;273(9):1871–95.

Article  CAS  PubMed  Google Scholar 

Mateja A, Wang Q, Chovanec J, Kim J, Wilson KJ, Schwartz LB, et al. Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis. J Allergy Clin Immunol. 2022;149(3):1010-7.e10.

Article  CAS  PubMed  Google Scholar 

White MV. The role of histamine in allergic diseases. J Allergy Clin Immunol. 1990;86(4 PART 2):599–605.

Article  CAS  PubMed  Google Scholar 

Lieberman P. The basics of histamine biology. Ann Allergy Asthma Immunol. 2011;106(2 SUPPL):S2-5.

Article  PubMed  Google Scholar 

Pollock I, Murdoch RD, Lessof MH. Plasma histamine and clinical tolerance to infused histamine in normal, atopic and urticarial subjects. Agents Actions. 1991;32(3–4):359–65.

Article  CAS  PubMed  Google Scholar 

Friedman BS, Steinberg SC, Meggs WJ, Kaliner MA, Frieri M, Metcalfe DD. Analysis of plasma histamine levels in patients with mast cell disorders. Am J Med. 1989;87(6):649–54.

Article  CAS  PubMed  Google Scholar 

Engevik AC, Kaji I, Goldenring JR. The physiology of the gastric parietal cell. Physiol Rev. 2020;100(2):573–602.

Article  CAS  PubMed  Google Scholar 

Wang B, Wu L, Chen J, Dong L, Chen C, Wen Z, et al. Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets. Signal Transduction and Targeted Therapy. 2021;6:1.

Google Scholar 

Ricciotti E, Fitzgerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 2011;31:986–1000.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kanaoka Y, Boyce JA. Cysteinyl leukotrienes and their receptors; emerging concepts. Allergy Asthma Immunol Res. 2014;6(4):288–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rouzer CA, Scott WA, Hamill AL, Cohn ZA. Synthesis of leukotriene C and other arachidonic acid metabolites by mouse pulmonary alveolar macrophages. J Exp Med. 1982;155:720–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rittchen S, Heinemann A. Therapeutic potential of hematopoietic prostaglandin D(2) synthase in allergic inflammation. Cells. 2019. https://doi.org/10.3390/cells8060619.

Article  PubMed  PubMed Central  Google Scholar 

Awad JA, Morrow JD, Roberts LJ 2nd. Detection of the major urinary metabolite of prostaglandin D2 in the circulation: demonstration of elevated levels in patients with disorders of systemic mast cell activation. J Allergy Clin Immunol. 1994;93(5):817–24.

Matsuoka T, Hirata M, Tanaka H, Takahashi Y, Murata T, Kabashima K, et al. Prostaglandin D2 as a mediator of allergic asthma. Science. 2000;287(5460):2013–7.

Article  CAS  PubMed  Google Scholar 

Williams TJ, Peck MJ. Role of prostaglandin-mediated vasodilatation in inflammation. Nature. 1977;270(5637):530–2.

Article  CAS  PubMed  Google Scholar 

Butterfield JH. Increased excretion of mast cell mediator metabolites during mast cell activation syndrome. J Allergy Clin Immunol Pract. 2023. https://doi.org/10.1016/j.jaip.2023.02.017.

Article  PubMed  PubMed Central  Google Scholar 

Peters-Golden M, Gleason MM, Togias A. Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis. Clin Exp Allergy. 2006;36(6):689–703.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cai C, Yang J, Hu S, Zhou M, Guo W. Relationship between urinary cysteinyl leukotriene E4 levels and clinical response to antileukotriene treatment in patients with asthma. Lung. 2007;185(2):105–12.

Article  CAS  PubMed  Google Scholar 

MacGlashan DW Jr., Schleimer RP, Peters SP, Schulman ES, Adams GK 3rd, Newball HH, et al. Generation of leukotrienes by purified human lung mast cells. J Clin Invest. 1982;70(4):747–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kanthawatana S, Carias K, Arnaout R, Hu J, Irani a, Schwartz LB. The potential clinical utility of serum alpha-protryptase levels. J Allergy Clin Immunol. 1999;103(6):1092–9.

Article  CAS  PubMed  Google Scholar 

Sperr WR, Jordan JH, Fiegl M, Escribano L, Bellas C, Dirnhofer S, et al. Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease. Int Arch Allergy Immunol. 2002;128(2):136–41.